DAVERLA Trademark

Trademark Overview

On Friday, January 15, 2016, a trademark application was filed for DAVERLA with the United States Patent and Trademark Office. The USPTO has given the DAVERLA trademark a serial number of 86876916. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2019. This trademark is owned by Sunovion Pharmaceuticals Inc.. The DAVERLA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for treating central nervous system diseases or disorders
daverla

General Information

Serial Number86876916
Word MarkDAVERLA
Filing DateFriday, January 15, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2016

Trademark Statements

Goods and Servicespharmaceutical preparations for treating central nervous system diseases or disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 21, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSunovion Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752
Party NameSunovion Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Trademark Events

Event DateEvent Description
Tuesday, September 3, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 2, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 8, 2019EXTENSION 5 GRANTED
Sunday, February 3, 2019EXTENSION 5 FILED
Friday, February 8, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, February 3, 2019TEAS EXTENSION RECEIVED
Saturday, August 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 2, 2018EXTENSION 4 GRANTED
Thursday, August 2, 2018EXTENSION 4 FILED
Thursday, August 2, 2018TEAS EXTENSION RECEIVED
Tuesday, February 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 2, 2018EXTENSION 3 GRANTED
Friday, February 2, 2018EXTENSION 3 FILED
Friday, February 2, 2018TEAS EXTENSION RECEIVED
Tuesday, July 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 21, 2017EXTENSION 2 GRANTED
Friday, July 21, 2017EXTENSION 2 FILED
Friday, July 21, 2017TEAS EXTENSION RECEIVED
Thursday, February 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 31, 2017EXTENSION 1 GRANTED
Tuesday, January 31, 2017EXTENSION 1 FILED
Tuesday, January 31, 2017TEAS EXTENSION RECEIVED
Tuesday, August 2, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 7, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 18, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 2, 2016ASSIGNED TO EXAMINER
Thursday, January 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 19, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

daverla system diseases disorders nervous central preparations treating pharmaceutical